Your browser doesn't support javascript.
loading
Lactose hydrolysis in packed-and fluidized-bed reactors using a recombinant ß-galactosidase immobilized on magnetic core-shell capsules.
Gennari, Adriano; Simon, Renate; Renard, Gaby; Chies, Jocelei Maria; Volpato, Giandra; Volken de Souza, Claucia Fernanda.
Afiliación
  • Gennari A; Laboratório de Biotecnologia de Alimentos, Universidade Do Vale Do Taquari - Univates, Av. Avelino Talini, Lajeado, RS, 171, ZC 95914-014, Brazil.
  • Simon R; Programa de Pós-Graduação Em Biotecnologia, Universidade Do Vale Do Taquari - Univates, Lajeado, RS, Brazil.
  • Renard G; Laboratório de Biotecnologia de Alimentos, Universidade Do Vale Do Taquari - Univates, Av. Avelino Talini, Lajeado, RS, 171, ZC 95914-014, Brazil.
  • Chies JM; Quatro G Pesquisa & Desenvolvimento Ltda, Porto Alegre, RS, Brazil.
  • Volpato G; Quatro G Pesquisa & Desenvolvimento Ltda, Porto Alegre, RS, Brazil.
  • Volken de Souza CF; Instituto Federal de Educação, Ciência e Tecnologia Do Rio Grande Do Sul - IFRS, Campus Porto Alegre, Porto Alegre, RS, Brazil.
Bioprocess Biosyst Eng ; 47(2): 263-273, 2024 Feb.
Article en En | MEDLINE | ID: mdl-38156992
ABSTRACT
The objective of this study was to develop a bioprocess for lactose hydrolysis in diverse dairy matrices, specifically skim milk and cheese whey, utilizing column reactors employing a core-shell enzymatic system featuring ß-galactosidase fused to a Cellulose Binding Domain (CBD) tag (ß-galactosidase-CBD). The effectiveness of reactor configurations, including ball columns and toothed columns operating in packed and fluidized-bed modes, was evaluated for catalyzing lactose hydrolysis in both skim milk and cheese whey. In a closed system, these reactors achieved lactose hydrolysis rates of approximately 50% within 5 h under all evaluated conditions. Considering the scale of the bioprocess, the developed enzymatic system was capable of continuously hydrolyzing 9.6 L of skim milk while maintaining relative hydrolysis levels of approximately 50%. The biocatalyst, created by immobilizing ß-galactosidase-CBD on magnetic core-shell capsules, exhibited exceptional operational stability, and the proposed bioprocess employing these column reactors showcases the potential for scalability.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leche / Lactosa Límite: Animals Idioma: En Revista: Bioprocess Biosyst Eng Asunto de la revista: BIOTECNOLOGIA / ENGENHARIA BIOMEDICA Año: 2024 Tipo del documento: Article País de afiliación: Brasil

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leche / Lactosa Límite: Animals Idioma: En Revista: Bioprocess Biosyst Eng Asunto de la revista: BIOTECNOLOGIA / ENGENHARIA BIOMEDICA Año: 2024 Tipo del documento: Article País de afiliación: Brasil